The Pyrimidinyl Hydrazones: Selective for anti-Cancer cytotoxicity

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Inorganic Chemistry

Background:

• Pyrimidinyl hydrazones (PH) are a class of compounds with potential therapeutic applications.
• Metal ions play crucial roles in biological processes, and their dysregulation is implicated in cancer.
• Developing novel anticancer agents with improved efficacy and reduced toxicity is a significant challenge.

Purpose of the Study:

• To synthesize and characterize novel pyrimidinyl hydrazones (PH).
• To evaluate the in vitro cytotoxic activity of PH against various human cancer cell lines.
• To investigate the role of metal ion complexation in the anticancer activity of PH.

Main Methods:

• Synthesis of 9 PH compounds starting from dichloropyrimidine.
• In vitro cytotoxicity assays using cancer and non-cancer cell lines.
• Determination of IC50 values and assessment of toxicity.
• Investigation of PH complexation with copper, iron, and zinc ions.

Main Results:

• PH compounds exhibited strong association with copper, iron, and zinc ions.
• Compound 15 demonstrated significant in vitro cytotoxicity against melanoma, ovarian, and pancreatic cancer cell lines (IC50 values 0.37, 0.11, 1.09 μM).
• PH showed minimal toxicity against non-cancer MRC-5 fibroblast cells (no toxicity at 25 μM).
• Copper complexes of PH displayed similar cytotoxicity but increased toxicity to non-cancer cells.
• Iron and zinc complexes did not generally enhance potency compared to PH alone.

Conclusions:

• Pyrimidinyl hydrazones are potent metal-chelating agents with significant in vitro anticancer activity.
• The mechanism of action likely involves metal mobilization and reactive oxygen species generation.
• PH represent a promising class of anticancer agents that warrant further extensive study.